ATC code M04
| ATC codes |
|---|
| M Musculo-skeletal system |
| M01 Anti-inflammatory and antirheumatic products |
| M02 Topical products for joint and muscular pain |
| M03 Muscle relaxants |
| M04 Antigout preparations |
| M05 Drugs for treatment of bone diseases |
| M09 Other drugs for disorders of the musculo-skeletal system |
|
|
ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M04A Antigout preparations
M04AA Preparations inhibiting uric acid production
- M04AA01 Allopurinol
- M04AA02 Tisopurine
- M04AA03 Febuxostat
- M04AA51 Allopurinol, combinations
M04AB Preparations increasing uric acid excretion
- M04AB01 Probenecid
- M04AB02 Sulfinpyrazone
- M04AB03 Benzbromarone
- M04AB04 Isobromindione
- M04AB05 Lesinurad
M04AC Preparations with no effect on uric acid metabolism
- M04AC01 Colchicine
- M04AC02 Cinchophen
M04AX Other antigout preparations
- M04AX01 Urate oxidase
- M04AX02 Pegloticase
References
- ↑ "ATC/DDD Index 2016: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia - version of the 1/6/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.